We are live on ! Find out more
MCM

Matterhorn Capital Management Portfolio holdings

AUM $151M
1-Year Est. Return 14.72%
This Fund
S&P 500
This Quarter Est. Return
+4.21%
1 Year Est. Return
+14.72%
3 Year Est. Return
+38.83%
5 Year Est. Return
10 Year Est. Return
AUM
$219M
AUM Growth
+$11.4M
Cap. Flow
+$6.33M
Cap. Flow %
2.89%
Top 10 Hldgs %
30.3%
Holding
58
New
5
Increased
35
Reduced
6
Closed
10

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.23M
2
MSFT icon
Microsoft
MSFT
+$5.2M
3
SBNY
Signature Bank
SBNY
+$3.93M
4
EXPD icon
Expeditors International
EXPD
+$3.67M
5
BIIB icon
Biogen
BIIB
+$3.57M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.96M
2
CF icon
CF Industries
CF
+$5.17M
3
HPQ icon
HP
HPQ
+$4.08M
4
WAB icon
Wabtec
WAB
+$3.35M
5
MIDD icon
Middleby
MIDD
+$3.32M

Sector Composition

Rank Sector Weight
1 Financials 26.11%
2 Healthcare 23.01%
3 Technology 21.15%
4 Communication Services 7.41%
5 Energy 5.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPQ icon
51
HP
HPQ
$27B
-351,195
Closed -$4.08M
LLY icon
52
Eli Lilly
LLY
$1.05T
-83,171
Closed -$6.96M
MIDD icon
53
Middleby
MIDD
$6.06B
-31,520
Closed -$3.32M
ORCL icon
54
Oracle
ORCL
$417B
-80,985
Closed -$2.92M
PII icon
55
Polaris
PII
$4.04B
-23,198
Closed -$2.78M
VRNT
56
DELISTED
Verint Systems
VRNT
-111,086
Closed -$2.44M
WAB icon
57
Wabtec
WAB
$49.8B
-38,084
Closed -$3.35M
AVG
58
DELISTED
AVG Technologies N.V.
AVG
-149,067
Closed -$3.24M

Similar funds

Matterhorn Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Matterhorn Capital Management held 58 positions worth $219M, up 5.5% from $207M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Matterhorn Capital Management's Q4 2015 filing shows 5 new, 35 increased, 6 reduced and 10 closed positions. Its largest new stake was Merck: 123,488 shares worth $6.22M. The largest sale was Eli Lilly, an estimated $6.96M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.

  • Matterhorn Capital Management's largest Q4 2015 buy was Merck: 123,488 shares worth $6.22M.
  • Matterhorn Capital Management added most to Criteo S.A. Ordinary Shares in Q4 2015, an estimated $1.71M increase.
  • Matterhorn Capital Management's biggest Q4 2015 reduction was Royal Dutch Shell PLC ADS Class A, cutting an estimated $54.4K.
  • Matterhorn Capital Management fully exited Eli Lilly in Q4 2015, selling an estimated $6.96M.
  • Matterhorn Capital Management's ten largest holdings make up 30% of its $219M portfolio in Q4 2015.
  • Matterhorn Capital Management opened 5 new positions and closed 10 in Q4 2015.
  • Matterhorn Capital Management's portfolio value rose 5.5% quarter-over-quarter to $219M.

Based on Matterhorn Capital Management's 13F filing for Q4 2015, filed 2 Feb 2016.